Cargando…
Cell death-based treatment of childhood cancer
Any therapy that aims at eradicating a cancerous growth will have at its core a cell death-inducing component. Here we argue that paediatric oncology presents with its unique set of considerations and problems, which—while taking the lead from oncological research experiences obtained from the adult...
Autores principales: | Westhoff, Mike-Andrew, Marschall, Nicolas, Grunert, Michael, Karpel-Massler, Georg, Burdach, Stefan, Debatin, Klaus-Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833432/ https://www.ncbi.nlm.nih.gov/pubmed/29371599 http://dx.doi.org/10.1038/s41419-017-0062-z |
Ejemplares similares
-
Killing Me Softly—Future Challenges in Apoptosis Research
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014) -
Comment in Response to “Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina”
por: Westhoff, Mike-Andrew, et al.
Publicado: (2020) -
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019) -
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014) -
Precision medicine in pediatric oncology
por: Burdach, Stefan E. G., et al.
Publicado: (2018)